Davenport Newberry Holdings LLC

Lazarus Naturals, a subsidiary of Etz Hayim Holdings Inc in Seattle, is a reputable manufacturer known for producing premium CBD oils, tinctures, and isolates. The company takes pride in their in-house production process, ensuring quality control from plant to bottle for all their CBD extracts. Generated from their website's infomation

Elliott Bay Design Group (EBDG) is a full-service marine engineering and naval architecture firm based in Seattle, WA, dedicated to supporting owners, operators, and shipyards in realizing a more sustainable and successful future. The company prides itself on the creativity and experience of its staff, which includes architects, engineers, analysts, designers, and support personnel who tackle complex challenges in the marine industry. Committed to community engagement and environmental sustainability, EBDG actively collaborates with local communities and integrates responsible practices into every aspect of its work. By fostering strong relationships and seeking innovative solutions, the firm aims to minimize its ecological footprint and contribute to the resilience of maritime ecosystems for generations to come. Generated from the website

Emerald Star Holdings, LLC is a leading scientific company based in Seattle, WA, specializing in early development assays, preclinical protein sciences, and bioanalytical services. With a strong focus on translational sciences and assay development, they offer expertise in infectious diseases, vaccines, immunotherapy, immuno-oncology, and metabolic diseases. Their team of renowned scientists and state-of-the-art laboratories enable them to provide comprehensive support to pharmaceutical and biotech companies in advancing their molecules to market. Nexelis, a Q Solutions company and a subsidiary of Emerald Star Holdings, LLC, is dedicated to immunology and vaccines. With over 20 years of experience in vaccine testing, Nexelis offers cutting-edge technology platforms, in-house custom in vivo services, and protein sciences capabilities to support candidate selection and assay development. They also specialize in immuno-oncology, providing functional profiling and evaluation of immunogenicity for candidate therapeutics. Additionally, Nexelis offers expertise in immunogenicity assessment and monitoring for biologics, as well as a long-standing history in the metabolic field. Through acquisitions and partnerships, they continue to expand their capabilities and excel in the scientific collaboration for various diseases and conditions.Generated from the website